Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 27, 2022

BUY
$72.36 - $113.1 $155,356 - $242,825
2,147 Added 8.13%
28,567 $2.07 Million
Q2 2022

Aug 10, 2022

BUY
$87.2 - $114.05 $56,505 - $73,904
648 Added 2.51%
26,420 $2.84 Million
Q1 2022

May 12, 2022

BUY
$94.19 - $124.49 $865,511 - $1.14 Million
9,189 Added 55.41%
25,772 $2.86 Million
Q4 2021

Feb 14, 2022

BUY
$119.57 - $139.07 $42,566 - $49,508
356 Added 2.19%
16,583 $2.13 Million
Q3 2021

Nov 08, 2021

SELL
$109.17 - $142.35 $126,746 - $165,268
-1,161 Reduced 6.68%
16,227 $2.16 Million
Q2 2021

Aug 11, 2021

SELL
$100.34 - $115.69 $111,076 - $128,068
-1,107 Reduced 5.99%
17,388 $1.88 Million
Q1 2021

May 11, 2021

SELL
$101.51 - $125.27 $126,989 - $156,712
-1,251 Reduced 6.34%
18,495 $1.94 Million
Q4 2020

Feb 11, 2021

SELL
$85.88 - $105.36 $13,740 - $16,857
-160 Reduced 0.8%
19,746 $2.05 Million
Q3 2020

Nov 09, 2020

BUY
$72.74 - $92.5 $30,187 - $38,387
415 Added 2.13%
19,906 $1.71 Million
Q2 2020

Aug 10, 2020

SELL
$48.02 - $79.04 $618,353 - $1.02 Million
-12,877 Reduced 39.78%
19,491 $1.43 Million
Q1 2020

Apr 24, 2020

BUY
$36.95 - $62.95 $188,223 - $320,667
5,094 Added 18.68%
32,368 $1.68 Million
Q4 2019

Feb 06, 2020

BUY
$47.06 - $56.64 $105,084 - $126,477
2,233 Added 8.92%
27,274 $1.54 Million
Q3 2019

Nov 01, 2019

SELL
$47.45 - $58.05 $63,915 - $78,193
-1,347 Reduced 5.1%
25,041 $1.19 Million
Q2 2019

Aug 08, 2019

BUY
$39.26 - $54.21 $29,876 - $41,253
761 Added 2.97%
26,388 $1.43 Million
Q1 2019

May 09, 2019

BUY
$29.84 - $43.92 $762,740 - $1.12 Million
25,561 Added 38728.79%
25,627 $1.04 Million
Q3 2018

Nov 01, 2018

BUY
$40.12 - $45.55 $2,647 - $3,006
66 New
66 $3,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Synovus Financial Corp Portfolio

Follow Synovus Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.